Hester Biosciences informs about outcome of board meeting

02 Feb 2024 Evaluate
Hester Biosciences has informed that Board of Directors, in their Meeting held today, have approved the unaudited standalone and consolidated financial results for the for the quarter and nine months period ended 31 December 2023, as recommended by Audit Committee. It has attached the approved unaudited standalone and consolidated financial results and limited review reports, A Press Release issued in this regard We will be publishing an extract of the results in the newspaper as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board Meeting commenced at 11:17 am (IST) and concluded at 12:05 pm (IST).

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1649.00 17.95 (1.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×